Filing Details
- Accession Number:
- 0001104659-21-055582
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-27 16:03:37
- Reporting Period:
- 2021-04-26
- Accepted Time:
- 2021-04-27 16:03:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1173281 | Neubase Therapeutics Inc. | NBSE | Pharmaceutical Preparations (2834) | 465622433 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1313876 | I Eric Richman | C/O 350 Technology Drive, Fourth Floor Pittsburgh PA 15219 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-04-26 | 5,000 | $5.00 | 41,080 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 27,747 | Indirect | See footnote |
Footnotes
- The power of attorney under which this form was signed is on file with the Commission.
- Shares are held in a trust for the benefit of the reporting person with the reporting person and the reporting person's spouse serving as co-trustees.